Genomtec

Genomtec Dividend Growth

Year-over-Year Dividend Growth of Genomtec (GMT.WA) as of Nov 10, 2026.

Dividend Growth

-

Last updated:

Year-over-Year Dividend Growth of Genomtec is 2026 - . Year-over-Year Dividend Growth of Genomtec was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomtec stock

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Genomtec since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Genomtec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Genomtec

All Key Metrics — Genomtec